comparemela.com

Page 69 - Nvo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Eli Lilly Stock Would Win Big If Weight-Loss Drug Market Hits $100 Billion

Eli Lilly and Denmark's Novo Nordisk are expected to roughly split the market for weight-loss drugs, both as diabetes and obesity treatments.

Daniel acker bloombergNovo nordiskCallum keownEli lillyArticle normalHealthcare life sciencesFinancial performanceSales figuresCorporate industrial newsPolitical general newsSociety communityMedical conditionsSocial issuesContent typesFactiva filtersC amp ampe industry news filter

ResMed shares can overcome obesity-drug craze, analysts say

Shares of ResMed Inc. which have been pounded in recent weeks by concerns that the obesity-drug craze could hurt demand for the company’s sleep therapy.

Resmed incNovo nordiskArticle normalHealth careResmed incNovo nordiskas adrS amp ampp 500 index

Weight-Loss Drug Stocks Are Soaring Why There s More Room to Run

Tesla has competition from Mercedes, Arm is targeting a $50 billion to $55 billion IPO valuation, and other news to start your day.

United statesNovo nordiskArticle normalIndustrial electrical equipmentMotor vehiclesAlternative fuel vehiclesHealthcare life sciencesIndustrial electronicsIndustrial goodsAnalysts amp 39 comments recommendationsCorporate industrial newsPolitical general newsPhysical mental fitnessLiving lifestyleWeight managementEquity markets

Novo Nordisk Is Europe s Biggest Company, Wegovy Helps Eli Lilly Could Benefit

The pharma company's Wegovy medication helps it overtake luxury goods maker LVMH, with a market value of around $420 billion.

Brian swintNovo nordisk wegovyEli lillyNovo nordiskExxon mobilGetty imagesNew england journalArticle normalHealthcare life sciencesFinancial performanceShare price movement disruptionsCorporate industrial newsContent typesFactiva filtersC amp ampe exclusion filterC amp ampe industry news filter

Novo Nordisk Launches Wegovy Weight-Loss Jab in UK

By Dominic Chopping Novo Nordisk launched its hugely popular Wegovy injectable weight-loss drug in the U.K. Monday, despite continuing challenges the company.

Moet hennessy louis vuittonUk national institute for healthNational health serviceNovo nordiskHennessy louis vuittonCare excellenceDominic choppingArticle normalHealthcare life sciencesConsumer goodsLuxury goodsPolitical general newsPhysical mental fitnessLiving lifestyleMedical conditionsWeight management

vimarsana © 2020. All Rights Reserved.